Philippine bill calls for new drug price commission
This article was originally published in Scrip
A Philippine congressman has filed a proposal calling for the establishment of a new independent commission to monitor the price of prescription drugs. Representative Narciso Santiago's house bill envisages the commission be tasked with reviewing prices in other reference countries, and monitoring and making recommendations on appropriate local price levels. It would also be responsible for proposing the structure, membership and function of a new price review board called for in cheaper medicines legislation approved earlier this year (Scrip Online, June 24th, 2008). The commission would in addition work out guidelines for starting prices and price increases, recommend fair pricing incentives for manufacturers and make regular reports to Congress, the bill states.
You may also be interested in...
Positive clinical results pave path forward for Japanese firm’s potential istradefylline successor.
Curon thinks tenalisib can offer a differentiated and safe new therapy for hematologic cancers such as multiple forms of lymphoma. Axis and PharmaEssentia team up on TCR therapy R&D in Taiwan.
Recent moves show Chinese biotech firms are increasingly looking to go global by recruiting world-class development talent, and J&J names new APAC pharma head.